 Dionysios Antonopoulos
Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteria | 14 | 2021 | 440 | 2.490 |
Why?
| | Biodiversity | 7 | 2016 | 206 | 1.220 |
Why?
| | Colitis | 5 | 2021 | 248 | 1.110 |
Why?
| | Feces | 9 | 2021 | 354 | 1.040 |
Why?
| | Metagenomics | 8 | 2020 | 89 | 0.990 |
Why?
| | Sulfates | 2 | 2021 | 62 | 0.850 |
Why?
| | Ruminococcus | 5 | 2010 | 9 | 0.850 |
Why?
| | Databases, Genetic | 4 | 2019 | 259 | 0.840 |
Why?
| | Drug Resistance, Microbial | 1 | 2019 | 132 | 0.790 |
Why?
| | Systems Integration | 1 | 2019 | 40 | 0.790 |
Why?
| | Computational Biology | 3 | 2019 | 529 | 0.770 |
Why?
| | Intestinal Mucosa | 12 | 2020 | 892 | 0.760 |
Why?
| | Sequence Analysis, DNA | 13 | 2017 | 884 | 0.690 |
Why?
| | RNA, Ribosomal, 16S | 15 | 2021 | 249 | 0.680 |
Why?
| | Interleukin-10 | 4 | 2021 | 157 | 0.670 |
Why?
| | Clostridium Infections | 2 | 2017 | 155 | 0.670 |
Why?
| | Ferric Compounds | 2 | 2021 | 40 | 0.660 |
Why?
| | Genome, Bacterial | 5 | 2016 | 143 | 0.650 |
Why?
| | Butyrates | 1 | 2016 | 37 | 0.650 |
Why?
| | Desulfotomaculum | 1 | 2016 | 2 | 0.640 |
Why?
| | Soil Microbiology | 1 | 2016 | 20 | 0.640 |
Why?
| | Acetic Acid | 1 | 2016 | 10 | 0.640 |
Why?
| | Interleukin-15 | 1 | 2016 | 69 | 0.630 |
Why?
| | Microbial Consortia | 1 | 2016 | 14 | 0.630 |
Why?
| | Intestines | 4 | 2019 | 424 | 0.600 |
Why?
| | Lactic Acid | 1 | 2016 | 119 | 0.600 |
Why?
| | Carbon | 3 | 2016 | 69 | 0.590 |
Why?
| | Metagenome | 8 | 2020 | 108 | 0.550 |
Why?
| | Gastrointestinal Tract | 4 | 2020 | 191 | 0.540 |
Why?
| | Glucose | 1 | 2016 | 624 | 0.490 |
Why?
| | Phylogeny | 14 | 2017 | 1119 | 0.490 |
Why?
| | Anti-Bacterial Agents | 6 | 2021 | 812 | 0.470 |
Why?
| | Colon | 5 | 2021 | 502 | 0.460 |
Why?
| | Nucleic Acid Hybridization | 4 | 2008 | 254 | 0.450 |
Why?
| | DNA, Bacterial | 8 | 2017 | 271 | 0.430 |
Why?
| | Nitrogen | 1 | 2010 | 67 | 0.420 |
Why?
| | Bivalvia | 1 | 2010 | 39 | 0.410 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 3175 | 0.400 |
Why?
| | Bacteroides | 2 | 2021 | 37 | 0.380 |
Why?
| | Gene Expression Profiling | 3 | 2011 | 1367 | 0.360 |
Why?
| | Base Sequence | 8 | 2016 | 2427 | 0.350 |
Why?
| | Animals | 30 | 2021 | 26934 | 0.340 |
Why?
| | DNA, Ribosomal | 5 | 2016 | 56 | 0.330 |
Why?
| | Pouchitis | 2 | 2017 | 52 | 0.320 |
Why?
| | Adaptive Immunity | 2 | 2019 | 162 | 0.320 |
Why?
| | Immunoglobulin A | 2 | 2017 | 98 | 0.310 |
Why?
| | Host-Pathogen Interactions | 3 | 2021 | 254 | 0.310 |
Why?
| | Molecular Sequence Data | 14 | 2012 | 3191 | 0.310 |
Why?
| | Gene Expression Regulation, Bacterial | 3 | 2010 | 231 | 0.300 |
Why?
| | Mice | 16 | 2020 | 11116 | 0.300 |
Why?
| | Immunity, Innate | 3 | 2019 | 428 | 0.290 |
Why?
| | Germ-Free Life | 4 | 2019 | 82 | 0.280 |
Why?
| | Chaperonin 10 | 1 | 2003 | 3 | 0.270 |
Why?
| | Chaperonin 60 | 1 | 2003 | 8 | 0.270 |
Why?
| | Glutamate Dehydrogenase | 1 | 2003 | 9 | 0.260 |
Why?
| | Genes, Bacterial | 2 | 2006 | 217 | 0.260 |
Why?
| | Toll-Like Receptor 4 | 2 | 2016 | 93 | 0.260 |
Why?
| | Gram-Positive Bacteria | 1 | 2003 | 27 | 0.250 |
Why?
| | Biodegradation, Environmental | 3 | 2021 | 33 | 0.240 |
Why?
| | Iron | 2 | 2021 | 166 | 0.240 |
Why?
| | Rumen | 4 | 2009 | 4 | 0.230 |
Why?
| | Oxidation-Reduction | 3 | 2021 | 379 | 0.230 |
Why?
| | Colitis, Ulcerative | 3 | 2017 | 687 | 0.230 |
Why?
| | Bacterial Proteins | 4 | 2010 | 897 | 0.230 |
Why?
| | Genetic Variation | 5 | 2016 | 1357 | 0.220 |
Why?
| | Mice, Knockout | 6 | 2021 | 1954 | 0.220 |
Why?
| | Diptera | 2 | 2011 | 46 | 0.210 |
Why?
| | Intestine, Small | 2 | 2015 | 343 | 0.210 |
Why?
| | Colonic Pouches | 2 | 2017 | 66 | 0.200 |
Why?
| | Immunity | 1 | 2020 | 115 | 0.200 |
Why?
| | Molecular Sequence Annotation | 1 | 2019 | 75 | 0.200 |
Why?
| | Groundwater | 2 | 2021 | 12 | 0.200 |
Why?
| | Milk Hypersensitivity | 1 | 2019 | 9 | 0.190 |
Why?
| | Disease Susceptibility | 2 | 2016 | 183 | 0.190 |
Why?
| | Anaphylaxis | 1 | 2019 | 34 | 0.190 |
Why?
| | Genomics | 4 | 2012 | 643 | 0.190 |
Why?
| | Internet | 2 | 2019 | 320 | 0.180 |
Why?
| | Food Hypersensitivity | 2 | 2019 | 61 | 0.180 |
Why?
| | Humans | 24 | 2021 | 83061 | 0.170 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2016 | 14 | 0.170 |
Why?
| | Ileitis | 1 | 2016 | 10 | 0.170 |
Why?
| | Oxalobacter formigenes | 1 | 2016 | 8 | 0.170 |
Why?
| | Biological Factors | 1 | 2016 | 18 | 0.170 |
Why?
| | Plasma Cells | 1 | 2017 | 104 | 0.170 |
Why?
| | Irritable Bowel Syndrome | 1 | 2017 | 38 | 0.170 |
Why?
| | Receptors, Pattern Recognition | 1 | 2016 | 26 | 0.160 |
Why?
| | Sepsis | 1 | 2020 | 299 | 0.160 |
Why?
| | Constipation | 1 | 2017 | 68 | 0.160 |
Why?
| | Panicum | 1 | 2016 | 5 | 0.160 |
Why?
| | Carbonates | 1 | 2016 | 5 | 0.160 |
Why?
| | Yersinia Infections | 1 | 2016 | 7 | 0.160 |
Why?
| | Gastrointestinal Motility | 1 | 2016 | 32 | 0.160 |
Why?
| | Ferrous Compounds | 1 | 2016 | 23 | 0.160 |
Why?
| | Oxalates | 1 | 2016 | 64 | 0.160 |
Why?
| | Proctocolectomy, Restorative | 1 | 2017 | 86 | 0.160 |
Why?
| | Yersinia enterocolitica | 1 | 2016 | 20 | 0.160 |
Why?
| | Electrons | 1 | 2016 | 50 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 1 | 2016 | 72 | 0.150 |
Why?
| | Phosphates | 1 | 2016 | 164 | 0.150 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 821 | 0.150 |
Why?
| | Epithelial Cells | 2 | 2016 | 627 | 0.150 |
Why?
| | Immunity, Humoral | 1 | 2015 | 79 | 0.140 |
Why?
| | Epsilonproteobacteria | 1 | 2014 | 4 | 0.140 |
Why?
| | Physical Conditioning, Animal | 1 | 2014 | 22 | 0.140 |
Why?
| | Immunization | 1 | 2014 | 163 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2016 | 265 | 0.130 |
Why?
| | Allergens | 1 | 2014 | 164 | 0.130 |
Why?
| | Male | 14 | 2020 | 41834 | 0.130 |
Why?
| | Embryo, Nonmammalian | 2 | 2011 | 209 | 0.130 |
Why?
| | Cluster Analysis | 5 | 2014 | 373 | 0.130 |
Why?
| | Androgens | 1 | 2013 | 154 | 0.130 |
Why?
| | Taurocholic Acid | 1 | 2012 | 8 | 0.130 |
Why?
| | Bilophila | 1 | 2012 | 5 | 0.120 |
Why?
| | Transcriptome | 1 | 2017 | 508 | 0.120 |
Why?
| | Autoimmunity | 1 | 2013 | 163 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2016 | 523 | 0.120 |
Why?
| | Conjunctiva | 1 | 2011 | 24 | 0.110 |
Why?
| | Autoimmune Diseases | 1 | 2013 | 232 | 0.110 |
Why?
| | Dietary Fats | 1 | 2012 | 165 | 0.110 |
Why?
| | Bacterial Infections | 1 | 2013 | 228 | 0.110 |
Why?
| | Female | 13 | 2020 | 44693 | 0.110 |
Why?
| | Triazines | 1 | 2011 | 48 | 0.110 |
Why?
| | Disease Models, Animal | 4 | 2021 | 2298 | 0.110 |
Why?
| | Microdissection | 1 | 2010 | 22 | 0.110 |
Why?
| | Cellulosomes | 2 | 2009 | 2 | 0.110 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 31 | 0.110 |
Why?
| | Water Movements | 1 | 2010 | 6 | 0.110 |
Why?
| | RNA, Messenger, Stored | 1 | 2010 | 5 | 0.110 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2011 | 130 | 0.110 |
Why?
| | Archaea | 1 | 2010 | 21 | 0.110 |
Why?
| | Software Design | 1 | 2009 | 18 | 0.100 |
Why?
| | Crohn Disease | 1 | 2016 | 714 | 0.100 |
Why?
| | Surface Properties | 1 | 2010 | 151 | 0.100 |
Why?
| | Amino Acid Sequence | 4 | 2010 | 2174 | 0.100 |
Why?
| | Genome, Viral | 1 | 2009 | 73 | 0.100 |
Why?
| | Water Pollutants, Chemical | 1 | 2011 | 133 | 0.100 |
Why?
| | Streptomycin | 1 | 2009 | 8 | 0.100 |
Why?
| | Fatty Acids, Volatile | 1 | 2009 | 20 | 0.100 |
Why?
| | Genetic Techniques | 1 | 2010 | 75 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2010 | 178 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2010 | 199 | 0.100 |
Why?
| | Enzymes | 1 | 2009 | 49 | 0.100 |
Why?
| | Glycoside Hydrolases | 1 | 2009 | 22 | 0.100 |
Why?
| | Genes, Insect | 1 | 2010 | 183 | 0.100 |
Why?
| | Gene Library | 2 | 2011 | 130 | 0.100 |
Why?
| | Cell Wall | 1 | 2009 | 61 | 0.100 |
Why?
| | Metabolomics | 1 | 2009 | 47 | 0.100 |
Why?
| | Databases, Nucleic Acid | 2 | 2009 | 43 | 0.090 |
Why?
| | Cattle | 2 | 2009 | 378 | 0.090 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2009 | 84 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2013 | 542 | 0.090 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2008 | 75 | 0.090 |
Why?
| | Electron Transport | 2 | 2021 | 71 | 0.090 |
Why?
| | Ileum | 2 | 2019 | 191 | 0.080 |
Why?
| | Obesity | 1 | 2014 | 966 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2010 | 654 | 0.070 |
Why?
| | Signal Transduction | 2 | 2020 | 3297 | 0.070 |
Why?
| | Cellulase | 1 | 2004 | 3 | 0.070 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2012 | 408 | 0.070 |
Why?
| | Ruminants | 1 | 2003 | 8 | 0.070 |
Why?
| | Ammonia | 1 | 2003 | 40 | 0.060 |
Why?
| | DNA Transposable Elements | 1 | 2004 | 168 | 0.060 |
Why?
| | Geologic Sediments | 2 | 2014 | 20 | 0.060 |
Why?
| | Transcription Factors | 1 | 2010 | 1512 | 0.060 |
Why?
| | DNA Primers | 1 | 2003 | 571 | 0.060 |
Why?
| | Sulfur Oxides | 1 | 2021 | 5 | 0.060 |
Why?
| | Anthraquinones | 1 | 2021 | 8 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2003 | 680 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2003 | 224 | 0.060 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2012 | 162 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 1936 | 0.060 |
Why?
| | Cefoperazone | 1 | 2020 | 9 | 0.060 |
Why?
| | B-Lymphocytes | 2 | 2017 | 793 | 0.060 |
Why?
| | Butyric Acid | 1 | 2020 | 12 | 0.050 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2020 | 16 | 0.050 |
Why?
| | Defensins | 1 | 2019 | 6 | 0.050 |
Why?
| | Cecum | 2 | 2010 | 74 | 0.050 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 81 | 0.050 |
Why?
| | Major Histocompatibility Complex | 1 | 2019 | 92 | 0.050 |
Why?
| | Principal Component Analysis | 1 | 2019 | 153 | 0.050 |
Why?
| | Inflammation | 2 | 2016 | 821 | 0.050 |
Why?
| | Sequence Homology | 2 | 2010 | 33 | 0.050 |
Why?
| | Gastrointestinal Contents | 1 | 1998 | 5 | 0.050 |
Why?
| | Immunocompromised Host | 1 | 2019 | 143 | 0.050 |
Why?
| | Lactobacillus | 1 | 1998 | 22 | 0.050 |
Why?
| | Digestive System | 1 | 1998 | 45 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2021 | 343 | 0.050 |
Why?
| | Prospective Studies | 2 | 2017 | 4067 | 0.050 |
Why?
| | Infant | 2 | 2019 | 3085 | 0.040 |
Why?
| | Peyer's Patches | 1 | 2017 | 24 | 0.040 |
Why?
| | Loperamide | 1 | 2017 | 9 | 0.040 |
Why?
| | STAT6 Transcription Factor | 1 | 2016 | 27 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2011 | 996 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1073 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 562 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2016 | 73 | 0.040 |
Why?
| | Ion Transport | 1 | 2016 | 84 | 0.040 |
Why?
| | Swine | 1 | 1998 | 569 | 0.040 |
Why?
| | Symbiosis | 1 | 2017 | 98 | 0.040 |
Why?
| | Hyperoxaluria | 1 | 2016 | 40 | 0.040 |
Why?
| | Mucous Membrane | 1 | 2016 | 103 | 0.040 |
Why?
| | Bacteroides fragilis | 1 | 2016 | 41 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 252 | 0.040 |
Why?
| | Toll-Like Receptor 1 | 1 | 2016 | 8 | 0.040 |
Why?
| | Antigens | 1 | 2017 | 270 | 0.040 |
Why?
| | Clostridium | 1 | 2014 | 37 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1167 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 62 | 0.040 |
Why?
| | Adult | 4 | 2017 | 25946 | 0.040 |
Why?
| | Gene Expression | 1 | 2019 | 1331 | 0.040 |
Why?
| | Sulfur | 1 | 2014 | 28 | 0.040 |
Why?
| | Hydrogen | 1 | 2014 | 55 | 0.030 |
Why?
| | Castration | 1 | 2013 | 39 | 0.030 |
Why?
| | Interleukins | 1 | 2014 | 122 | 0.030 |
Why?
| | Living Donors | 1 | 2017 | 298 | 0.030 |
Why?
| | Muscles | 1 | 2014 | 196 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2014 | 241 | 0.030 |
Why?
| | Plasmids | 1 | 2014 | 296 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2015 | 724 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2014 | 102 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2013 | 181 | 0.030 |
Why?
| | Weight Gain | 1 | 2014 | 138 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2016 | 971 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 380 | 0.030 |
Why?
| | Safflower Oil | 1 | 2012 | 13 | 0.030 |
Why?
| | Taurine | 1 | 2012 | 17 | 0.030 |
Why?
| | Sulfites | 1 | 2012 | 24 | 0.030 |
Why?
| | Cytokines | 1 | 2016 | 748 | 0.030 |
Why?
| | Milk | 1 | 2012 | 49 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2012 | 40 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2012 | 47 | 0.030 |
Why?
| | Sigmoidoscopy | 1 | 2012 | 42 | 0.030 |
Why?
| | Chronic Disease | 1 | 2016 | 964 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3698 | 0.030 |
Why?
| | Genes, rRNA | 1 | 2011 | 10 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 1425 | 0.030 |
Why?
| | Biotransformation | 1 | 2011 | 56 | 0.030 |
Why?
| | Th1 Cells | 1 | 2012 | 159 | 0.030 |
Why?
| | Time Factors | 1 | 2021 | 5497 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 182 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2013 | 461 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2013 | 309 | 0.030 |
Why?
| | Lymphocytes | 1 | 2013 | 475 | 0.030 |
Why?
| | Disease Progression | 1 | 2016 | 1470 | 0.030 |
Why?
| | Information Dissemination | 1 | 2012 | 99 | 0.030 |
Why?
| | Carbohydrate Metabolism | 1 | 2010 | 32 | 0.030 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2010 | 40 | 0.030 |
Why?
| | Human Experimentation | 1 | 2010 | 42 | 0.030 |
Why?
| | Jejunum | 1 | 2010 | 104 | 0.030 |
Why?
| | Epithelium | 1 | 2011 | 321 | 0.030 |
Why?
| | Mothers | 1 | 2011 | 128 | 0.030 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2010 | 56 | 0.030 |
Why?
| | Programming Languages | 1 | 2010 | 18 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 806 | 0.030 |
Why?
| | Macrophages | 1 | 2013 | 556 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1521 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2010 | 220 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2010 | 188 | 0.030 |
Why?
| | Salmonella Infections, Animal | 1 | 2009 | 12 | 0.030 |
Why?
| | Cell Polarity | 1 | 2010 | 120 | 0.020 |
Why?
| | Bacterial Translocation | 1 | 2009 | 46 | 0.020 |
Why?
| | Biocatalysis | 1 | 2009 | 52 | 0.020 |
Why?
| | Isoptera | 1 | 2009 | 8 | 0.020 |
Why?
| | Salmonella typhimurium | 1 | 2009 | 35 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2009 | 121 | 0.020 |
Why?
| | Metabolism | 1 | 2009 | 25 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2010 | 287 | 0.020 |
Why?
| | Pilot Projects | 1 | 2011 | 832 | 0.020 |
Why?
| | Food | 1 | 2009 | 84 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1287 | 0.020 |
Why?
| | Body Patterning | 1 | 2010 | 233 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2010 | 384 | 0.020 |
Why?
| | Species Specificity | 1 | 2009 | 683 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 923 | 0.020 |
Why?
| | Infant, Premature | 1 | 2009 | 287 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 702 | 0.020 |
Why?
| | Diarrhea | 1 | 2008 | 206 | 0.020 |
Why?
| | Genome | 1 | 2010 | 357 | 0.020 |
Why?
| | Reference Values | 1 | 2008 | 699 | 0.020 |
Why?
| | Biopsy | 1 | 2010 | 1178 | 0.020 |
Why?
| | Drosophila melanogaster | 1 | 2011 | 602 | 0.020 |
Why?
| | Cellulose | 1 | 2006 | 59 | 0.020 |
Why?
| | Environment | 1 | 2008 | 219 | 0.020 |
Why?
| | Multigene Family | 1 | 2006 | 215 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2008 | 973 | 0.020 |
Why?
| | Diet | 1 | 2009 | 447 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2004 | 139 | 0.020 |
Why?
| | Recurrence | 1 | 2008 | 1194 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2010 | 2969 | 0.020 |
Why?
| | Young Adult | 1 | 2017 | 5958 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2011 | 825 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2010 | 1992 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2009 | 1825 | 0.020 |
Why?
| | DNA | 1 | 2010 | 1300 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2009 | 2430 | 0.020 |
Why?
| | Algorithms | 1 | 2012 | 1841 | 0.020 |
Why?
| | Middle Aged | 2 | 2012 | 25577 | 0.010 |
Why?
| | RNA | 1 | 2004 | 511 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1998 | 49 | 0.010 |
Why?
|
|
Antonopoulos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|